Effectiveness of Sound Acupuncture in Painful Chemotherapy-Related Neuropathies: A Non-Invasive Alternative to Acupuncture? Pilot Study
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Pain reduction
Study Overview
Brief Summary
The objective of this clinical trial is to evaluate the efficacy of sound acupuncture in combination with traditional medical therapy in the treatment of chemotherapy-induced peripheral neuropathies.
Sound acupuncture is a non-invasive technique that involves stimulating energy points, used in acupuncture, with the help of specific tuning forks and the frequencies they emit.
The energy points are those used in Chinese medicine and, more specifically, in acupuncture.
The aim is to restore the recipient's complex bioenergetic system to an optimal state of well-being and balance
Participants:
20 patients will receive only the best medical therapy; 20 patients will receive BMT and sound acupuncture treatment
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 30 Years to 80 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Age 30-80 years
- •Clinical and electrophysiological diagnosis of chemotherapy-induced neuropathy
- •Patients being treated with Best Medical Therapy for neuropathic pain
- •Written informed consent
Exclusion Criteria
- •Women who are pregnant or breastfeeding
- •Patients with intellectual disabilities or cognitive impairment that impair their ability to comply with the consent process
- •Pacemaker users
Arms & Interventions
Sound acupuncture
Best medical therapy + Sound Acupuncture
Intervention: Sound acupuncture (Other)
BMT
Best medical therapy
Outcomes
Primary Outcomes
Pain reduction
Time Frame: 1 year
At least a 30% reduction from baseline on the NPS scale for neuropathic pain
Secondary Outcomes
- Back Depression inventory(1 year)
- Quality of life assessment(1 year)
Investigators
Andrea Assini
MD
Ente Ospedaliero Ospedali Galliera